Patient No.
|
Sex
|
Age (y)
|
Location
|
Clinically Suspected Involvement
|
Preoperative Diagnosis
|
VM
|
VT
|
Final Diagnosis
|
Treatment
|
Hospital Stay
|
|
1 |
M |
72 |
RUL |
SVC |
Squamous |
Nodes 4R- |
SVC- |
Squamous |
Pneumonectomy |
5 days |
|
|
|
|
Nodes 4R |
|
|
Nodule RLL- |
|
|
|
|
|
|
|
Nodule RLL |
|
|
|
|
|
|
2 |
M |
60 |
LUL |
Proximal PA |
Squamous |
TB angle- |
Proximal PA- |
Squamous |
Pneumonectomy |
5 days |
|
|
|
|
TB angle |
|
Nodes 4L- |
Aorta- |
|
|
|
|
|
|
|
Aorta |
|
|
Nodes 5- |
|
|
|
|
|
|
|
Nodes 4L and 5 |
|
|
|
|
|
|
3 |
F |
62 |
LUL |
PA |
|
Nodes 4L and 7- |
PA- |
Adenocarcinoma |
Pneumonectomy |
5 days |
|
|
|
|
Nodes 4L, 5, 6, and 7 |
|
|
Nodes 5 and 6- |
|
|
|
4 |
M |
61 |
LUL |
TB angle |
Squamous |
TB angle- |
Nodes 6+ |
Squamous |
Neoadjuvant chemotherapy and pneumonectomy |
2 days |
|
|
|
|
Nodes 4R, 5, and 6 |
|
Nodes 4R- |
|
|
|
|
5 |
F |
66 |
LLL |
Pleural effusion |
Squamous |
Nodes 4L- |
Pleura- |
Squamous |
Neoadjuvant chemotherapy and pneumonectomy |
2 days |
|
|
|
|
Nodes 4L, and 5 |
|
|
Nodes 5+ |
|
|
|
6 |
M |
61 |
LUL |
Nodes 4R, 4L, and 6 |
|
Nodes 4R and 4L- |
Nodes 6+ |
Neuroendocrine |
Neoadjuvant chemotherapy and lobectomy |
2 days |
7 |
M |
60 |
LUL |
Nodes 4R, 5, and 6 |
|
Nodes 4R- |
Nodes 6+ |
Oat cell |
Chemotherapy |
2 days |
8 |
M |
67 |
LUL |
Proximal PA |
|
Nodes 4R, 4L, and 7- |
Proximal PA+ |
Oat cell |
Chemotherapy |
2 days |
|
|
|
|
Aorta |
|
|
Aorta+ |
|
|
|
|
|
|
|
Pleural effusion |
|
|
Pleura- |
|
|
|
|
|
|
|
Nodes 4R, 4L, and 7 |
|
|
|
|
|
|
9 |
M |
71 |
RUL |
Pleural effusion |
|
Nodes 4R- |
Pleura+ |
Adenocarcinoma |
Chemotherapy |
3 days |
|
|
|
|
Nodes 4R |
|
|
|
|
|
|
10 |
M |
70 |
RUL |
Chest wall |
|
Nodes 2R and 4R+ |
Chest wall+ |
Leiomyosarcoma |
Chemotherapy |
2 days |
|
|
|
|
Pleural effusion |
|
|
Pleura- |
|
|
|
|
|
|
|
Nodes 2R, and 4R
|
|
|
|
|
|
| |